NRB Inc. (KOSDAQ:475230)
16,280
+990 (6.47%)
Aug 8, 2025, 3:30 PM KST
Ligand Pharmaceuticals Revenue
NRB Inc. had revenue of 10.68B KRW in the quarter ending March 31, 2025. This brings the company's revenue in the last twelve months to 44.99B. In the year 2024, NRB Inc. had annual revenue of 52.80B with 2.46% growth.
Revenue (ttm)
44.99B
Revenue Growth
+2.46%
P/S Ratio
3.77
Revenue / Employee
616.27M
Employees
73
Market Cap
169.75B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 52.80B | 1.27B | 2.46% |
Dec 31, 2023 | 51.53B | 33.54B | 186.34% |
Dec 31, 2022 | 18.00B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition